SQSTM1 and cancer: Cancer cells benefit from increased levels of p62 (that may be caused by autophagy impairment), as it provides them with an improved antioxidant and detoxifying response (Nrf2 activation) and proangiogenic and prosurvival signals (NF‐κB activation), both of which promote tumor progression.